Senior insider sale
Chief Executive Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$2.50M
91.24K shares
What this filing means
CONGLETON JON plans to sell 91.24K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $2.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001964306-26-000191
DirectorOfficer· Chief Executive Officer
Since Feb 2026
91.24K
Shares to sell
$2.50M
Approx. market value
75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Vesting of restricted share unit award
Granted as part of issuer equity compensation plan
7/10/2024
11.34KVesting of restricted share unit award
Granted as part of issuer equity compensation plan
6/10/2024
63.66KTotal acquired75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/10/2024 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 11.34K | — |
6/10/2024 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 63.66K | — |
| Total | 75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.24K
Market value
$529.6K
1/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
75K
Market value
$1.97M
3/31/2026
Total
Units
91.24K
Value
$2.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/12/2026 | 16.24K | $529.6K | — | Completed |
| Planned — Approximate Date | ||||
3/31/2026 | 75K | $1.97M | NASDAQ | Planned |
| Total | 91.24K | $2.50M | ||